Dysfunctions of innate and adaptive immune tumor microenvironment in Waldenström macroglobulinemia-Reference-Cited by-同舟云学术

Dysfunctions of innate and adaptive immune tumor microenvironment in Waldenström macroglobulinemia

Published:2022-12-30 Issue:9 Volume:152 Page:1947-1963
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Intl Journal of Cancer

Author:

Cholujova Danka¹²,Beke Gabor³,Hunter Zachary R.⁴⁵,Hideshima Teru⁵⁶,Flores Ludmila⁵⁶,Zeleznikova Tatiana⁷,Harrachova Denisa⁸,Klucar Lubos³,Leiba Merav⁹,Drgona Lubos¹⁰,Treon Steven P.⁴⁵,Kastritis Efstathios¹¹,Dorfman David M.¹²,Anderson Kenneth C.⁵⁶,Jakubikova Jana¹²⁵⁶^ORCID

Affiliation:

1. Department of Tumor Immunology, Cancer Research Institute, Biomedical Research Center Slovak Academy of Sciences Bratislava Slovakia

2. Centre for Advanced Materials Application Slovak Academy of Sciences Bratislava Slovakia

3. Institute of Molecular Biology Slovak Academy of Sciences Bratislava Slovakia

4. Bing Center for Waldenström Macroglobulinemia Dana Farber Cancer Institute Boston Massachusetts USA

5. Department of Medicine Harvard Medical School Boston Massachusetts USA

6. Department of Medical Oncology, Dana Farber Cancer Institute Jerome Lipper Multiple Myeloma Center Boston Massachusetts USA

7. Department of Oncohematology St. Elizabeth Cancer Institute Hospital Bratislava Slovakia

8. Department of Oncohematology Hospital Cyril and Methodius Bratislava Slovakia

9. Assuta Ashdod University Hospital, Faculty of Health Science Ben‐Gurion University of the Negev Negev Israel

10. Department of Oncohematology Comenius University and National Cancer Institute Bratislava Slovakia

11. Department of Clinical Therapeutics, School of Medicine National and Kapodistrian University of Athens Athens Greece

12. Department of Pathology Brigham and Women's Hospital Boston Massachusetts USA

Funder

Agentúra na Podporu Výskumu a Vývoja

National Institutes of Health

Slovenská Akadémia Vied

Vedecká Grantová Agentúra MŠVVaŠ SR a SAV

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.34405

Reference41 articles.

1. The 2016 revision of the World Health Organization classification of lymphoid neoplasms

2. Recommendations for the diagnosis and initial evaluation of patients with Waldenström Macroglobulinaemia: A Task Force from the 8th International Workshop on Waldenström Macroglobulinaemia

3. Immunophenotypic analysis of Waldenstrom's macroglobulinemia

4. Targeting cell adhesion and homing as strategy to cure Waldenström's macroglobulinemia

5. Circulating Soluble Receptor Activator of Nuclear Factor Kappa B Ligand and C-C Motif Ligand 3 Correlate With Survival in Patients With Waldenström Macroglobulinemia

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PembroWM: A phase II trial to investigate the safety and efficacy of rituximab and pembrolizumab in relapsed/refractory Waldenström's Macroglobulinaemia;British Journal of Haematology;2024-08-19

2. Immune profiles to predict bortezomib-based treatment response for multiple myeloma patients;International Immunopharmacology;2024-03

3. B-cell specific expression of the murineMyd88^L252Pmutation correlates with the establishment of an immunosuppressive microenvironnement in Waldenström macroglobulinemia lymphoplasmacytic lymphoma;2023-09-29

4. Clonal architecture and evolutionary history of Waldenström's macroglobulinemia at the single-cell level;Disease Models & Mechanisms;2023-08-01